Ashton Thomas Private Wealth’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.69M | Buy |
24,544
+2,604
| +12% | +$180K | 0.06% | 310 |
|
|
2025
Q1 | $1.55M | Sell |
21,940
-424
| -2% | -$29.9K | 0.06% | 299 |
|
|
2024
Q4 | $1.92M | Buy |
22,364
+6,454
| +41% | +$555K | 0.07% | 278 |
|
|
2024
Q3 | $1.89M | Buy |
15,910
+1,165
| +8% | +$139K | 0.1% | 221 |
|
|
2024
Q2 | $2.1M | Buy |
14,745
+209
| +1% | +$29.8K | 0.12% | 189 |
|
|
2024
Q1 | $1.87M | Buy |
14,536
+2,374
| +20% | +$305K | 0.11% | 212 |
|
|
2023
Q4 | $1.26M | Buy |
12,162
+6,210
| +104% | +$642K | 0.08% | 257 |
|
|
2023
Q3 | $541K | Buy |
5,952
+1,482
| +33% | +$135K | 0.04% | 384 |
|
|
2023
Q2 | $362K | Buy |
+4,470
| New | +$362K | 0.03% | 455 |
|